- Home
- Johnson & Johnson
Johnson & Johnson
Quiz: How much do you really know about taking care of your eyes?
Around the world, more than 1 billion people have impaired vision—but 80% of these cases are preventable with early diagnosis and treatment. Ready to test your eye IQ with our quiz?
6 top questions about COVID-19: What a child psychiatrist has to say
On the latest episode of The Road to a Vaccine, host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
What you need to know about Johnson & Johnson’s 2020 second-quarter earnings
Check out this infographic breakdown of the company’s second-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.
“I was working on a potential COVID-19 vaccine—Then my wife got sick”: Meet a researcher whose personal experience is fueling his fight against the pandemic
Within a matter of weeks, Ramon Polo’s work and home life were completely changed by the novel coronavirus—and he’s a stronger scientist and husband for it.
Chairman and CEO Alex Gorsky discusses Johnson & Johnson’s response to COVID-19 at the Fortune Brainstorm Health Conference
Watch a video of Gorsky’s interview at the virtual summit, which includes the latest information on the company’s pursuit of a potential COVID-19 vaccine.
Break a bone badly? You could be a candidate for this innovative 3-D printed medical device
The Trumatch® Graft Cage – Long Bone is a cutting-edge device that could revolutionize trauma care—and help improve outcomes for patients who have the kind of catastrophic bone injuries that can happen in car accidents.
Johnson & Johnson and its partners mark a milestone in the quest for a global preventive HIV vaccine with the Imbokodo Study
The clinical trial has completed full immunizations of the company’s investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
“AIDS won’t stop for COVID-19": Meet 3 inspiring women who are as committed as ever to making HIV history
For World AIDS Day, three attendees of the virtual 2020 International AIDS Society Conference, including activist and actress Laverne Cox, talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.
6 latest facts about Johnson & Johnson’s Ebola vaccine
In response to a new Ebola outbreak in Guinea, Johnson & Johnson is providing up to 200,000 doses of its Ebola vaccine regimen to the country for a World Health Organization supported clinical trial. Learn more about the initiative and other top facts about the vaccine regimen for the deadly virus.
“What COVID-19 has taught me": 7 Johnson & Johnson researchers reveal lessons they’ve learned from the pandemic
From scientists working on a potential vaccine to medically trained employees who mobilized to the front lines to help treat patients, these men and women share what most resonates for them about the unique and devastating virus, both professionally and personally.